Introduction: There are two major categories of peroxisomal disorders (PDs): peroxisomal biogenesis disorders (PBDs) due to defects in peroxisomal (PEX) genes and deficiency of other peroxisomal enzymes (such as D-bifunctional enzyme deficiency due to HSD17B4). PDs are characterized by abnormal elevations of very-long-chain fatty acids (VLCFA). We aimed to evaluate the clinical phenotype of adrenal insufficiency in patients with PD and to assess any genotype-phenotype correlations with adrenal insufficiency. Case Presentation: We performed a retrospective electronic medical record review at a single university medical center, of data over 12 years and identified 7 patients with PD. Of the 7 patients identified, 6 patients had a diagnosis of PBD and one had a single peroxisomal enzyme deficiency, HSD17B4. The average age of the patients at diagnosis were 0.61 ± 0.66 years. Four patients (66.7%) had primary adrenal insufficiency: 3, out of the 4, patients had elevated baseline ACTH. Three patients failed to have increased response after the Cortrosyn™ stimulation test. Three patients were on daily hydrocortisone replacement, and 1 patient was on stress-dose hydrocortisone only as needed. Specific genetic variant analysis revealed that all the 3 patients with PBD and adrenal insufficiency who were on steroid supplementation had the compound heterozygous pathogenic variant in exon 13 of PEX1 c.2097dupT (p.Ile700Tyrfs*42) and c.2528G>A (p.Gly843Asp), while the 1 patient with peroxisomal enzyme deficiency and adrenal insufficiency had compound heterozygous pathogenic variants in HSD17B4 c.1369A>T (p.Asn457Tyr) and c.1210 − 1G>A (splice acceptor). Two of these patients with PEX1 variants also required mineralocorticoid supplementation. The 3 PBD patients without adrenal insufficiency did not have a PEX1 variant. Discussion/Conclusion: Primary adrenal insufficiency is common in patients with PD. Based on our data, patients with the compound heterozygous PEX1 pathogenic variants of exon 13 (c.2097dupT and c.2528G>A) tend to have adrenal insufficiency. Aldosterone deficiency, though rare, can occur in PD.

1.
Powers
JM
,
Tummons
RC
,
Caviness
VS
Jr
,
Moser
AB
,
Moser
HW
.
Structural and chemical alterations in the cerebral maldevelopment of fetal cerebro-hepato-renal (Zellweger) syndrome
.
J Neuropathol Exp Neurol
.
1989
;
48
(
3
):
270
89
.
2.
Steinberg
SJ
,
Dodt
G
,
Raymond
GV
,
Braverman
NE
,
Moser
AB
,
Moser
HW
.
Peroxisome biogenesis disorders
.
Biochim Biophys Acta
.
2006
;
1763
(
12
):
1733
48
.
3.
Wanders
RJA
,
Waterham
HR
.
Peroxisomal disorders: the single peroxisomal enzyme deficiencies
.
Biochim Biophys Acta
.
2006
;
1763
(
12
):
1707
20
.
4.
Distel
B
,
Erdmann
R
,
Gould
SJ
,
Blobel
G
,
Crane
DI
,
Cregg
JM
,
.
A unified nomenclature for peroxisome biogenesis factors
.
J Cell Biol
.
1996
;
135
(
1
):
1
3
.
5.
Purdue
PE
,
Zhang
JW
,
Skoneczny
M
,
Lazarow
PB
.
Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor
.
Nat Genet
.
1997
;
15
(
4
):
381
4
.
6.
Whitcomb
RW
,
Linehan
WM
,
Knazek
RA
.
Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro
.
J Clin Invest
.
1988
;
81
(
1
):
185
8
.
7.
Richards
S
,
Aziz
N
,
Bale
S
,
Bick
D
,
Das
S
,
Gastier-Foster
J
,
.
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology
.
Genet Med
.
2015
;
17
(
5
):
405
24
.
8.
Poll-The
BT
,
Gootjes
J
,
Duran
M
,
De Klerk
JBC
,
Wenniger-Prick
LJMd B
,
Admiraal
RJC
.
Peroxisome biogenesis disorders with prolonged survival: phenotypic expression in a cohort of 31 patients
.
Am J Med Genet A
.
2004
;
126A
(
4
):
333
8
.
9.
Berendse
K
,
Engelen
M
,
Linthorst
GE
,
van Trotsenburg
ASP
,
Poll-The
BT
.
High prevalence of primary adrenal insufficiency in Zellweger spectrum disorders
.
Orphanet J Rare Dis
.
2014
;
9
:
133
.
10.
Wangler
MF
,
Hubert
L
,
Donti
TR
,
Ventura
MJ
,
Miller
MJ
,
Braverman
N
,
.
A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers
.
Genet Med
.
2018
;
20
(
10
):
1274
83
.
11.
Govaerts
L
,
Sippell
WG
,
Monnens
L
.
Further analysis of the disturbed adrenocortical function in the cerebro-hepato-renal syndrome of Zellweger
.
J Inherit Metab Dis
.
1989
;
12
(
4
):
423
8
.
12.
Powers
JM
,
Schaumburg
HH
,
Johnson
AB
,
Raine
CS
.
A correlative study of the adrenal cortex in adreno-leukodystrophy--evidence for a fatal intoxication with very long chain saturated fatty acids
.
Invest Cell Pathol
.
1980
;
3
(
4
):
353
76
.
13.
Knazek
RA
,
Rizzo
WB
,
Schulman
JD
,
Dave
JR
.
Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy
.
J Clin Invest
.
1983
;
72
(
1
):
245
8
.
14.
Van den Branden
C
,
Collumbien
R
,
Roels
F
,
Dacremont
G
,
Roels
H
.
Altered adrenocortical response under the influence of experimentally increased serum very long chain fatty acids in rats
.
Pathol Res Pract
.
1993
;
189
(
5
):
558
62
.
15.
Goldfischer
S
,
Powers
JM
,
Johnson
AB
,
Axe
S
,
Brown
FR
,
Moser
HW
.
Striated adrenocortical cells in cerebro-hepato-renal (Zellweger) syndrome
.
Virchows Arch A Pathol Anat Histopathol
.
1983
;
401
(
3
):
355
61
.
16.
Baarine
M
,
Andreoletti
P
,
Athias
A
,
Nury
T
,
Zarrouk
A
,
Ragot
K
,
.
Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins
.
Neuroscience
.
2012
;
213
:
1
18
.
17.
Baarine
M
,
Ragot
K
,
Athias
A
,
Nury
T
,
Kattan
Z
,
Genin
EC
,
.
Incidence of Abcd1 level on the induction of cell death and organelle dysfunctions triggered by very long chain fatty acids and TNF-alpha on oligodendrocytes and astrocytes
.
Neurotoxicology
.
2012
;
33
(
2
):
212
28
.
18.
Hein
S
,
Schonfeld
P
,
Kahlert
S
,
Reiser
G
.
Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture
.
Hum Mol Genet
.
2008
;
17
(
12
):
1750
61
.
19.
Zhou
J
,
Terluk
MR
,
Orchard
PJ
,
Cloyd
JC
,
Kartha
RV
.
N-acetylcysteine reverses the mitochondrial dysfunction induced by very long-chain fatty acids in murine oligodendrocyte model of adrenoleukodystrophy
.
Biomedicines
.
2021
;
9
(
12
):
1826
.
You do not currently have access to this content.